These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 31679863)

  • 21. Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline.
    Nelson EA; Bloom DE; Mahoney RT
    PLoS One; 2014; 9(2):e89593. PubMed ID: 24586899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global Routine Vaccination Coverage, 2018.
    Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
    Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
    PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
    Lim SS; Stein DB; Charrow A; Murray CJ
    Lancet; 2008 Dec; 372(9655):2031-46. PubMed ID: 19070738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
    Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
    Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.
    Saxenian H; Hecht R; Kaddar M; Schmitt S; Ryckman T; Cornejo S
    Health Policy Plan; 2015 Mar; 30(2):197-205. PubMed ID: 24510369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries' supply chain transformations in 2016-2020.
    Brooks A; Habimana D; Huckerby G
    Vaccine; 2017 Apr; 35(17):2110-2114. PubMed ID: 28364917
    [No Abstract]   [Full Text] [Related]  

  • 29. Global Routine Vaccination Coverage - 2017.
    VanderEnde K; Gacic-Dobo M; Diallo MS; Conklin LM; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(45):1261-1264. PubMed ID: 30439873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New vaccine introductions in Africa before and during the decade of vaccines - Are we making progress?
    Sambala EZ; Wiyeh AB; Ngcobo N; Machingaidze S; Wiysonge CS
    Vaccine; 2019 May; 37(25):3290-3295. PubMed ID: 31076160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
    Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
    Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries.
    Munk C; Portnoy A; Suharlim C; Clarke-Deelder E; Brenzel L; Resch SC; Menzies NA
    BMC Health Serv Res; 2019 Oct; 19(1):741. PubMed ID: 31640687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges to sustainable immunization systems in Gavi transitioning countries.
    Cernuschi T; Gaglione S; Bozzani F
    Vaccine; 2018 Oct; 36(45):6858-6866. PubMed ID: 30268735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving immunization capacity in Ethiopia through continuous quality improvement interventions: a prospective quasi-experimental study.
    Manyazewal T; Mekonnen A; Demelew T; Mengestu S; Abdu Y; Mammo D; Abebe W; Haffa B; Zenebe D; Worku B; Aman A; Tigabu S
    Infect Dis Poverty; 2018 Nov; 7(1):119. PubMed ID: 30497515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domestic funding opportunities for Tanzania as five new Middle-Income countries brace for reduced Gavi support for immunization.
    Thomas Mori A; Christopher Bulula N; Magodi R; Mwengee W
    Vaccine; 2022 May; 40(24):3278-3285. PubMed ID: 35527062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.
    Dadari I; Higgins-Steele A; Sharkey A; Charlet D; Shahabuddin A; Nandy R; Jackson D
    Vaccine; 2021 Apr; 39(17):2434-2444. PubMed ID: 33781603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.